Urogenital Abnormalities: Clinical Trials

9 trials for Urogenital Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 3 unknown, 1 terminated, 1 withdrawn. 9 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 19Recruiting 4, Unknown 3, Terminated 1, Withdrawn 1

Follow Urogenital Abnormalities: new trials by email Literature Review of Urogenital Abnormalities trials Research Report on Urogenital Abnormalities

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Saxenda - Panhypopituitarism, Craniopharyngioma
Early Phase 1UnknownSeoul National University Hospital502022-11-282024-01-23
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
Spironolactone, Placebo - Hyperandrogenism, Polycystic Ovary Syndrome
Early Phase 1RecruitingUniversity of Virginia322021-11-122025-08-05
Concomitant Renal and Urinary Bladder Allograft Transplantation
Concomitant Renal and Urinary Bladder Allograft Transplantation - Chronic Kidney Diseases, Bladder Dysfunction
Early Phase 1RecruitingMayo Clinic302021-06-012026-09-24
Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?
Spironolactone - Polycystic Ovary Syndrome, Puberty Disorders
Early Phase 1UnknownUniversity of Virginia242019-12-182023-10-27
The Role of Local Long Acting Corticosteroid Injection in Hypospadias Surgery.
steroid betamethasone - Hypospadias
Early Phase 1UnknownCairo University402019-12-012019-12-12
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
Replens and coconut oil - Genitourinary Abnormality, Breast Cancer Female
Early Phase 1TerminatedAlta Bates Summit Medical Center142016-11-182018-07-26
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
Micronized progesterone, Spironolactone, Placebo - Hyperandrogenism, Polycystic Ovary Syndrome
Early Phase 1RecruitingUniversity of Virginia322016-07-212025-08-05
CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women
CDB-2914 - Urogenital Abnormalities
Early Phase 1WithdrawnEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2011-11-082019-12-17
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
Micronized progesterone suspension, Placebo - Puberty, Hyperandrogenism
Early Phase 1RecruitingUniversity of Virginia362008-06-012025-08-05

Narrower conditions

Hyperandrogenism (4)  ·  Polycystic Ovary Syndrome (4)  ·  Bladder Exstrophy (1)  ·  Combined Pituitary Hormone Deficiency (1)  ·  Craniopharyngioma (1)  ·  Dyspareunia (1)  ·  Dysuria (1)  ·  Edema (1)  ·  Fistula (1)  ·  Hypospadias (1)  ·  Metrorrhagia (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sexual Infantilism (1)

Broader conditions

Congenital Abnormalities (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Male Urogenital Diseases (9)  ·  Urogenital Diseases (9)  ·  Genital Diseases (7)  ·  Genital Diseases, Female (6)  ·  Disorders of Sex Development (5)  ·  Endocrine System Diseases (5)  ·  Gonadal Disorders (5)  ·  Neoplasms (5)  ·  46, XX Disorders of Sex Development (4)  ·  Adnexal Diseases (4)

Interventions

Spironolactone (3)  ·  Progesterone (2)  ·  Coconut Oil (1)  ·  Liraglutide (1)  ·  Replens (1)  ·  ulipristal (1)

Sponsors

University of Virginia (4)  ·  Alta Bates Summit Medical Center (1)  ·  Cairo University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Mayo Clinic (1)  ·  Seoul National University Hospital (1)

Countries

United States (6)  ·  Egypt (1)  ·  South Korea (1)

Top investigators

Christine Burt Solorzano, MD (2)  ·  Alicia Y Christy, M.D. (1)  ·  Christine Burt Solorzano, M.D. (1)  ·  Christine M Burt Solorzano, MD (1)  ·  Patricio Gargollo, MD (1)  ·  Uma Suryadevara, MD (1)

Results publications

PMID 23481118, PMID 29300925

NIH funding

P50HD028934 (1), R01HD102060 (1)